TITLE

Opportunities and Options for Treatment Research in Resource-Constrained Settings

AUTHOR(S)
Volberding, Paul A.
PUB. DATE
July 2003
SOURCE
Clinical Infectious Diseases;7/1/2003 Supplement 1, Vol. 37, pS1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
HIV clinical research faces limitations even in research-rich settings. Even though important questions remain unanswered, clinical trials will probably never be conducted that address, prospectively, when treatment is optimally indicated, for example. In resource-constrained settings, large, prospective clinical trials are also unlikely. On the other hand, ones with a more observational design or that compare cohort experiences may well be feasible and able to provide information important in those settings, as well as in regions with abundant financial resources.
ACCESSION #
10361821

 

Related Articles

  • Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long-Term Nonprogressors in the US Department of Defense HIV Natural History Study. Okulicz, Jason F.; Marconi, Vincent C.; Landrum, Michael L.; Wegner, Scott; Weintrob, Amy; Ganesan, Anuradha; Hale, Braden; Crum-Cianflone, Nancy; Delmar, Judith; Barthel, Vincent; Quinnan, Gerald; Agan, Brian K.; Dolan, Matthew J. // Journal of Infectious Diseases;12/1/2009, Vol. 200 Issue 11, p1714 

    Durable control of human immunodeficiency virus (HIV) replication and lack of disease progression in the absence of antiretroviral therapy were studied in a military cohort of 4586 subjects. We examined groups of elite controllers (ie, subjects with plasma HIV RNA levels of <50 copies/mL;...

  • A HEALTHY DOSE OF information. Lynde, Michelle // Alive: Canada's Natural Health & Wellness Magazine;Dec2007, Issue 302, p46 

    The article describes the two categories of medical research, observational research and experimental research. Observational research includes a range of studies such as case-control studies and cohort studies. Experimental research on the other hand is generally conducted in phases, the...

  • Initial Treatment of HIV Infection: Randomized Trials with Clinical End Points Are Still Needed. Hughes, Michael D. // Journal of Infectious Diseases;9/1/2006, Vol. 194 Issue 5, p542 

    The author reflects on the studies presented by the Antiretroviral Treatment Cohort Collaboration which compare rates of progression of AIDS-defining illness of death in a initial highly active antiretroviral therapy. He argues that the randomized trial recognized as the best study design for...

  • Comparative Efficacy versus Effectiveness of Initial Antiretroviral Therapy in Clinical Trials versus Routine Care. Routman, Justin S.; Willig, James H.; Westfall, Andrew O.; Abroms, Sarah R.; Varshney, Mohit; Adusumilli, Sunil; Allison, Jeroan J.; Savage, Karen G.; Saag, Michael S.; Mugavero, Michael J. // Clinical Infectious Diseases;2/15/2010, Vol. 50 Issue 4, p574 

    Background. The applicability of clinical trial findings (efficacy) to the routine care setting (effectiveness) may be limited because of study eligibility criteria and volunteer bias. Although well-chronicled in many conditions, the efficacy versus effectiveness of antiretroviral therapy (ART)...

  • Interventions to Reduce 30-Day Rehospitalization: A Systematic Review. Hansen, Luke O.; Young, Robert S.; Hinami, Keiki; Leung, Alicia; Williams, Mark V. // Annals of Internal Medicine;10/18/2011, Vol. 155 Issue 8, p520 

    The article focuses on a systematic review related to the medical procedures and treatment which should be adopted to reduce the incidences of rehospitalization of patients within 30 days of getting discharged from the hospital. The review found that minimizing the cases of rehospitalization...

  • Poster 15: A Successful Short- and Long-Term Recruiting Strategy for Huntington Clinical Trials: A Community Effort Goodman, L.; Carnes, R.; Giuliano, J.; Vetter, L. // Neurotherapeutics;Jan2010, Vol. 7 Issue 1, p142 

    Objective: To determine short- and long-term effects on recruitment rates following community-delivered education sessions within a cohort of Huntington disease (HD) support group members in the Pacific Northwest. Background: There has been no systematic measure or comparison of methods utilized...

  • Rethinking pragmatic randomised controlled trials: introducing the "cohort multiple randomised controlled trial" design. Relton, Clare; Torgerson, David; O'Cathain, Alicia; Nicholl, Jon // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;5/1/2010, Vol. 340 Issue 7753, p963 

    The "cohort multiple randomised controlled trial" (cmRCT) design tackles some of the problems associated with pragmatic trial designs, such as recruitment. The cmRCT design has several innovative features: a large observational cohort of patients is recruited and used as a multiple trials...

  • Evaluating the Strength of Clinical Recommendations in the Medical Literature: GRADE, SORT, and AGREE. Maymone, Mayra Buainain de Castro; Gan, Stephanie D; Bigby, Michael // Journal of Investigative Dermatology;Oct2014, Vol. 134 Issue 10, pe25 

    The article offers information related to grading systems including Grading of Recommendations Assessment, Development, and Evaluation (GRADE), Strength of Recommendation Taxonomy (SORT) and Appraisal of Guidelines Research and Evaluation (AGREE) to rate the strength of the clinical practices...

  • Poster 22: Cooperative Huntington Observational Research Trial (COHORT): Baseline Mental Health Risks  // Neurotherapeutics;Jan2009, Vol. 6 Issue 1, p211 

    Background: COHORT is a prospective observational study enrolling research participants with manifest Huntington disease (HD), pre-manifest HD, 50% risk for HD, and family members with no risk for HD. Major objectives are to provide systematic clinical assessments and associated biological...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics